Study details
Enrolling now
Escitalopram for Asthma Exacerbations
University of Texas Southwestern Medical Center
NCT IDNCT06216535ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
105
Study length
about 4 years
Ages
18–75
Locations
1 site in TX
About this study
This trial is testing whether escitalopram helps reduce asthma exacerbations in adults with frequent attacks. Participants will take either escitalopram or a placebo, and the number of asthma exacerbations will be tracked over 1474 days.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Escitalopram
- 2.Take Placebo
PhasePhase 2
DrugEscitalopram
Routeoral
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low10%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
escitalopram (SSRI; increases serotonin availability)
Drug routes
oral (Oral Tablet)
Body systems
Respiratory